Reisner Y, Dagan S
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Trends Biotechnol. 1998 Jun;16(6):242-6. doi: 10.1016/s0167-7799(98)01203-7.
Monoclonal antibodies of human origin may have great therapeutic value in the treatment of cancer, autoimmune disorders and viral or bacterial infections. Several methods for generating human monoclonal antibodies exist; some are based on the transplantation of a functioning human immune system into severe combined immunodeficient (scid) mice or into Trimera mice, which are mice that have been lethally irradiated and radioprotected by transplantation of bone-marrow cells from scid mice. Trimera mice could be also used to develop animal models for human diseases by transplanting infected human tissue fragments and for creating models for cell therapy.
源自人类的单克隆抗体在癌症、自身免疫性疾病以及病毒或细菌感染的治疗中可能具有巨大的治疗价值。存在几种产生人类单克隆抗体的方法;一些基于将正常运作的人类免疫系统移植到严重联合免疫缺陷(scid)小鼠或Trimera小鼠体内,Trimera小鼠是经过致死性照射并通过移植scid小鼠的骨髓细胞进行辐射防护的小鼠。Trimera小鼠还可用于通过移植受感染的人类组织片段来开发人类疾病的动物模型,以及用于创建细胞治疗模型。